Published in Diabetes Care on October 01, 2001
Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol (2012) 1.05
Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy. Clin Pediatr Endocrinol (2008) 0.84
7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8-10, 2014, Helsinki, Finland. Diabetes Technol Ther (2014) 0.80
The evidence base for diabetes technology: appropriate and inappropriate meta-analysis. J Diabetes Sci Technol (2013) 0.79
Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes. Exp Ther Med (2014) 0.79
Evolving trends in insulin delivery in pursuit of improvements in diabetes management. Am Health Drug Benefits (2010) 0.77
Assessing quality of life for new diabetes treatments and technologies: a simple patient-centered score. J Diabetes Sci Technol (2007) 0.77
Comparison of continuous subcutaneous insulin infusion versus basal/bolus insulin injections for treatment of type 1 diabetes in clinical practice. J Diabetes Sci Technol (2009) 0.75
Insulin pump therapy versus multiple daily injections. Curr Diab Rep (2002) 0.75
Insulin pumps are still debatable for type 1 diabetes. BMJ (2002) 0.75
[Guidelines for insulin pump therapy in children and adults]. Wien Klin Wochenschr (2012) 0.75
ViDa1: The Development and Validation of a New Questionnaire for Measuring Health-Related Quality of Life in Patients with Type 1 Diabetes. Front Psychol (2017) 0.75
[Insulin pump therapy in children, adolescents and adults]. Wien Klin Wochenschr (2016) 0.75
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Haemophilus influenzae type B resistant to ampicillin. A report of two cases. JAMA (1974) 9.56
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (1999) 7.00
Reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests. Science (1974) 5.32
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ (1998) 4.95
Laparoscopic techniques versus open techniques for inguinal hernia repair. Cochrane Database Syst Rev (2003) 4.93
High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer (2004) 3.75
Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A (1989) 3.55
Ramipril and the development of diabetes. JAMA (2001) 3.38
Does induction of labour increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes. BJOG (2013) 3.37
Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial. Lancet (1994) 3.29
Stability of insulin lispro in insulin infusion systems. Diabetes Care (1997) 3.16
The risk of unexplained antepartum stillbirth in second pregnancies following caesarean section in the first pregnancy. BJOG (2008) 3.07
The mind's scalpel in surgical education: a randomised controlled trial of mental imagery. BJOG (2012) 2.71
The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care (1997) 2.68
Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care (2001) 2.57
Status of nonoperative management of blunt hepatic injuries in 1995: a multicenter experience with 404 patients. J Trauma (1996) 2.53
Troglitazone action is independent of adipose tissue. J Clin Invest (1997) 2.50
Socio-economic deprivation and stage of disease at presentation in women with breast cancer. Ann Oncol (2000) 2.45
Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A (1999) 2.40
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care (2000) 2.34
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab (2012) 2.23
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG (2014) 2.20
Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q (1996) 2.16
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes Obes Metab (2009) 2.04
RAC, a stable ribosome-associated complex in yeast formed by the DnaK-DnaJ homologs Ssz1p and zuotin. Proc Natl Acad Sci U S A (2001) 1.94
Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. Lancet (1990) 1.94
Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res (2001) 1.92
Blunt splenic injury in adults: Multi-institutional Study of the Eastern Association for the Surgery of Trauma. J Trauma (2000) 1.86
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial. Diabet Med (2013) 1.84
Overweight among children and adolescents in a Native Canadian community: prevalence and associated factors. Am J Clin Nutr (2000) 1.76
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab (2010) 1.76
Insulins today and beyond. Lancet (2001) 1.71
Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ (2008) 1.61
Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care (1997) 1.55
Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr (1998) 1.53
Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later. Am J Respir Crit Care Med (1994) 1.51
Randomised controlled trial of effect of Baby Check on use of health services in first 6 months of life. BMJ (1999) 1.51
Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications. JAMA (1972) 1.51
Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart (2003) 1.51
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia (2008) 1.50
The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab (1999) 1.50
Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development (1999) 1.50
"There is a chain of Chinese whispers ...": empirical data support the call to formally teach handover to prequalification doctors. Qual Saf Health Care (2009) 1.49
Computer use by general practitioners in Scotland. Br J Gen Pract (1998) 1.47
Symptomatic outcome 1 year after laparoscopic and minilaparotomy cholecystectomy: a randomized trial. Br J Surg (1995) 1.44
Conceptions and uses of public health ideas by New Zealand government policymakers: report on a five-agency survey. Public Health (2005) 1.43
Staphylococcal susceptibility to penicillin G. The changing pattern among community strains. JAMA (1974) 1.41
The duty of confidence. Br Med J (Clin Res Ed) (1982) 1.41
The increasing incidence of Ampicillin-resistant Haemophilus influenzae. A cause of otitis media. JAMA (1978) 1.40
What happens when doctors stop prescribing temazepam? Use of alternative therapies. Br J Gen Pract (1998) 1.40
Stillbirth in twins, exploring the optimal gestational age for delivery: a retrospective cohort study. BJOG (2014) 1.40
Abortion must not be advocated as preventive solution to unwanted pregnancy. BMJ (1997) 1.39
Value of early postoperative plain radiography following BOP fusion in cervical spinal surgery. Br J Neurosurg (1997) 1.39
Selection of plasma for hepatitis B immune globulin using a low cost radioimmunoassay. Vox Sang (1981) 1.38
Limulus lysate test for gram-negative bacterial meningitis. Bedside application. JAMA (1975) 1.38
Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab (1987) 1.37
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme. Diabetes Obes Metab (2012) 1.34
Antioxidant intake and adult-onset wheeze: a case-control study. Aberdeen WHEASE Study Group. Eur Respir J (1999) 1.34
Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care (1999) 1.33
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes (1996) 1.31
The genomic map position of the adenovirus type 2 glycoprotein. Virology (1979) 1.29
Cerebrospinal fluid lactic acid levels in meningitis. J Pediatr (1977) 1.28
Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol (2000) 1.27
Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract (2005) 1.27
Alternative routes of insulin delivery. Diabet Med (2003) 1.24
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and Europe. Diabet Med (2006) 1.24
The prevalence of adult onset wheeze: longitudinal study. BMJ (1997) 1.23
Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. J Obstet Gynaecol Can (2003) 1.22
Body image concepts differ by age and sex in an Ojibway-Cree community in Canada. J Nutr (1996) 1.22
The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol (2001) 1.21
Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant (2001) 1.20
Physical activity, physical fitness, and insulin and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care (2001) 1.20
Nursing in genitourinary medicine: 10 years on from the Monks Report. The membership of GUNA. Genito-Urinary Nurses Association. Int J STD AIDS (1999) 1.19
A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON). Diabetes Obes Metab (2014) 1.18
Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes (1977) 1.17
The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arterioscler Thromb Vasc Biol (2000) 1.16
Characterization of Alzheimer's beta -secretase protein BACE. A pepsin family member with unusual properties. J Biol Chem (2000) 1.16
Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med (2000) 1.15
DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol (1981) 1.15
Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia (2005) 1.15
The nasopharyngeal culture in acute otitis media. A reappraisal of its usefulness. JAMA (1979) 1.15
Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers. J Hum Genet (1999) 1.14
A reevaluation of osseous surgery. Dent Clin North Am (1969) 1.14
Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care (2000) 1.12
Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases. Am J Dis Child (1977) 1.12
Office hypertension in type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.12
Characterization of the novel brown adipocyte cell line HIB 1B. Adrenergic pathways involved in regulation of uncoupling protein gene expression. J Cell Sci (1994) 1.11
Ultrasound-guided percutaneous tracheal puncture: a computer-tomographic controlled study in cadavers. Br J Anaesth (2011) 1.11
Heterochromatin-like regions as ecological niches for avirulence genes in the Leptosphaeria maculans genome: map-based cloning of AvrLm6. Mol Plant Microbe Interact (2007) 1.10
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia (2011) 1.10